Guide detail

Post-Surgery Recovery Protocol

This protocol combines multiple peptides to maximize tissue repair, reduce inflammation, and accelerate recovery post-surgery. It is designed for advanced users with prior peptide experience and focuses on synergistic effects while minimizing receptor desensitization.

Pre-Surgery Preparation (1-2 weeks prior):

  • Begin BPC-157 (250-500 mcg/day, subQ) to pre-condition tissues and reduce inflammation.
  • Start TB-500 (2.5 mg, twice weekly, subQ) to promote angiogenesis and cell migration.
  • Administer GHK-Cu (2-5 mg/day, subQ) to support collagen synthesis and immune modulation.

Post-Surgery (Day 1-14):

  • BPC-157: 500 mcg twice daily (morning and evening, subQ) near the surgical site if possible.
  • TB-500: 2.5 mg every 3 days (subQ) for systemic healing support.
  • GHK-Cu: 5 mg/day (subQ) to enhance wound healing and reduce oxidative stress.
  • Ipamorelin + CJC-1295 (no DAC): 100-300 mcg each, 1-2x daily (morning and/or pre-bed, subQ) to boost GH secretion. Avoid dosing within 2 hours of meals.
  • Tesamorelin: 1 mg/day (subQ, pre-bed) for additional GH pulse synergy. Rotate injection sites.

Week 3-6 (Maintenance Phase):

  • Reduce BPC-157 to 250 mcg twice daily (subQ).
  • TB-500: 2.5 mg every 5 days (subQ).
  • GHK-Cu: 2-3 mg/day (subQ).
  • Ipamorelin + CJC-1295: Reduce to 100 mcg each, 1x daily (pre-bed).
  • Tesamorelin: Discontinue after Week 4 to prevent GH axis suppression.

Cycle Length & Timing:

  • Total cycle duration: 6 weeks (adjust based on healing progress).
  • Avoid overlapping GH-secretagogues (Ipamorelin/CJC/Tesamorelin) within 4 hours to prevent desensitization.
  • Alternate injection sites (e.g., abdomen, thighs) to prevent lipoatrophy.

Supportive Measures:

  • Hydrate excessively (3-4L/day) to support kidney function (GHK-Cu is copper-bound).
  • Pair with vitamin C (1-2g/day) to enhance collagen synthesis.
  • Monitor blood glucose (GH peptides may cause transient insulin resistance).

Notes

  • Synergy: BPC-157 and TB-500 target localized and systemic healing, respectively. GHK-Cu complements extracellular matrix repair. Ipamorelin/CJC/Tesamorelin amplify endogenous GH for protein synthesis.
  • Timing: Morning/pre-bed dosing for GH peptides mimics natural pulsatility.
  • Copper Caution: GHK-Cu may cause nausea; split doses if needed.

Warnings

  • Consult a physician before use, especially post-surgery (bleeding risk with GH peptides).
  • Avoid combining with NSAIDs (may blunt BPC-157 effects).
  • Discontinue if severe hypersensitivity (e.g., TB-500 allergy) occurs.
  • Monitor for joint pain (high-dose GH peptides may cause fluid retention).
  • Do not exceed 6 weeks without a break (GH axis suppression risk).

References

  • BPC-157: Study on tendon healing (PMID: 21030672).
  • TB-500: Angiogenesis effects (PMID: 15037013).
  • GHK-Cu: Wound repair (PMID: 29986520).
  • CJC-1295/Ipamorelin: GH release kinetics (PMID: 16352683).
  • Tesamorelin: FDA guidance for lipodystrophy. (PMID: 21687371)